Novotech Brand Video from Novotech on Vimeo. BOSTON, Oct. 03, 2023 (Korea Bizwire) – Novotech, the leading Asia Pacific centred biotech CRO with global execution capabilities, announced today the appointment of Dr. Judith Ng-Cashin as Chief Medical Officer (CMO). Learn more about Dr. Judith Ng-Cashin here Dr. Ng-Cashin, who brings 20 years of international pharmaceutical, biotech, [...]
SINGAPORE, Sept. 19, 2023 (Korea Bizwire) -- Novotech, the leading Asia Pacific centred biotech CRO with global execution capabilities has just been awarded for the second consecutive year the Best CRO for Cell & Gene Therapy 2023 at the Asia Pacific Cell & Gene Therapy Excellence Awards. Novotech’s Vice President, Clinical Services Dr. Yooni Kim accepted the award at [...]
BOSTON, Sept. 11, 2023 (Korea Bizwire) – Novotech, the leading Asia Pacific centred biotech CRO with global execution capabilities, announced today an expert panel webinar on Clinical Trials in China: Unlocking the Potential of Advanced Therapies. Novotech is collaborating with Endpoints News to jointly host this webinar. The webinar will examine how China’s focus on cutting-edge innovations and [...]
BOSTON, Sept. 7 (Korea Bizwire) – Novotech, the leading Asia Pacific centred biotech CRO with global execution capabilities, today published the latest specialist clinical trial report –“Gallbladder Cancer: Global Clinical Trials Landscape Report”. According to the report, biopharma companies have initiated approximately 250 ongoing clinical trials in gallbladder cancer (GBC) since 2016, with the Asia-Pacific region [...]
BOSTON, Sept. 7 (Korea Bizwire) – Novotech, the leading Asia Pacific centred biotech CRO with global execution capabilities, today published the latest specialist clinical trial report – “Nasopharyngeal Carcinoma: Global Clinical Trial Landscape”. According to the report, since 2018, the biopharma industry has initiated over 200 global clinical trials for nasopharyngeal carcinoma (NPC), with 60% of these [...]
SINGAPORE, July 13 (Korea Bizwire) — Novotech, the leading Asia Pacific centred biotech CRO with global execution capabilities is a finalist in the Asia Pacific Cell & Gene Therapy Awards 2023. The winner will be announced at the 7th Cell & Gene Therapy World Asia in Singapore on 13 September 2023. Novotech is currently the recipient of the Asia Pacific Cell & Gene Therapy [...]
SEOUL, Korea, July 10 (Korea Bizwire) — Novotech, the leading Asia Pacific centred biotech CRO with global execution capabilities will present a technical session at BIOPLUS-INTERPHEX KOREA 2023 for biotechs planning regional or global trials. Novotech’s Vice President, Global Head of Clinical Services Yooni Kim will open the session which will be followed by presentations [...]
BOSTON, June 21 (Korea Bizwire) — Novotech, the leading Asia Pacific centred biotech CRO with global execution capabilities has been selected for the prestigious CRO Leadership Award 2023 for exceeding biotech customer expectations in the “Compatibility” category. The award will be officially presented at the 2023 CRO Leadership Awards Ceremony, June 27th in Boston. The global award is [...]
BOSTON, May 29 (Korea Bizwire) — Novotech, the leading Asia Pacific centred biotech CRO is sponsoring the BIO 2023 APAC Summit, and the Endpoints session on Forging New Biotech Ties with China. Novotech CCO Barry Murphy is a panelist on the APAC Summit session Diversity and Beyond – Tapping the potential of the Asia Pacific for Clinical Trials. Novotech, a biotech [...]
CHICAGO, May 25 (Korea Bizwire) — Novotech, the leading Asia Pacific centred biotech CRO is sponsoring key oncology focussed expert events for ASCO: a pre-ASCO Summit with eChina Health, and a webinar panel discussion on accelerating development of advanced therapies with Endpoints. Meet with the Novotech team at ASCO here Novotech, which has more than [...]